Version 2.0 of the Draft CRI Guidelines 2025 introduces updated examination procedures for AI, blockchain, and quantum-based inventions, and includes an extensive annexure of examples clarifying Section 3(k)…
Gaurav Mishra · 1 Jul 2025
The Delhi High Court upheld the refusal of Lummus Novolen’s patent for a Ziegler-Natta catalyst, citing lack of inventive step and similarity to prior art. Read the key…
Neetha Mohan · 30 Jun 2025
The Calcutta High Court remanded Shindengen Electric’s 2015 patent application after finding that the rejection order lacked proper reasoning. The decision emphasised the need for administrative transparency and…
Gaurav Mishra · 26 Jun 2025
This post breaks down why patents are expensive, detailing costs across various stages, from drafting to international filings. It also explains how thoughtful investment in patent services ensures…
Gaurav Mishra · 24 Jun 2025
The Himachal Pradesh High Court granted an interim injunction in favour of SML Limited, restraining the defendants from manufacturing and selling a fertilizer composition under the brand ‘Aladdin’,…
Dr. Kalyan Kankanala · 23 Jun 2025
This post analyzes the Delhi High Court’s decision in Dura-Line vs. Jain Irrigation, where the Court found patent infringement but rejected the design infringement claim.
Sowmya S Murthy · 17 Jun 2025
The Madras High Court has ruled in favour of Tekelec Inc., setting aside the rejection of its patent application under Section 3(k) of the Indian Patents Act. The…
Dr. Kalyan Kankanala · 11 Jun 2025
The Calcutta High Court has set aside the refusal of ITC’s patent application for a nicotine aerosol device. The Court found that the Controller’s reliance on morality grounds…
Intellepedia · 5 Jun 2025
The Madras High Court has allowed Kemin Industries' patent on an enzyme-based animal feed method, overturning the Controller’s Section 3(i) refusal. The Court ruled that the method involves…
Intellepedia · 4 Jun 2025
In a recent ruling, the Delhi High Court overturned the rejection of an anti-cancer patent filed by Taiho Pharmaceutical. The Court highlighted that objections under Section 3(d) must…
Neetha Mohan · 3 Jun 2025